Jun 26, 2019
1:4
For every 4 shares held, investors received 1. The price per share adjusted from $159.00 to $636.00.
The split itself did not change the total investment value.
Symbio Pharmaceuticals Limited (TSE:4582) operates in the Pharmaceuticals: major industry.
Symbio Pharmaceuticals Limited company overviewSymbio Pharmaceuticals Limited's most recent stock split was on June 26, 2019. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
Symbio Pharmaceuticals Limited has split its stock once. This history records one reverse split, on June 26, 2019.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Symbio Pharmaceuticals Limited's 1-for-4 reverse split on June 26, 2019, every 4 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Symbio Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on June 26, 2019, 7 years ago. Companies announce splits in advance, and any new TSE:4582 split will appear on this page.
Already premium?